CornerCap Investment Counsel »

Adicet Bio shares owned by CornerCap Investment Counsel

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by CornerCap Investment Counsel from 13F filings

Historical chart of CornerCap Investment Counsel investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by CornerCap Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by CornerCap Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 38k 1.89
2023-09-30 $52k 38k 1.37
2023-06-30 $94k 39k 2.43

More positions owned by CornerCap Investment Counsel

Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Cisco Systems (CSCO)
Apple (AAPL)
CSX Corporation (CSX)
Microsoft Corporation (MSFT)
Emerson Electric (EMR)
Merck & Co (MRK)
Booking Holdings (BKNG)
Fnf (FNF)
Bristol Myers Squibb (BMY)
Intel Corporation (INTC)

View all positions for CornerCap Investment Counsel

Top funds holding Adicet Bio

OrbiMed Advisors
Cowen And Company
Carlyle
Vanguard Group
Millennium Management
Tang Capital Management
Two Sigma Advisers
Norges Bank Investment Management
Two Sigma Investments
D. E. Shaw & Co
Schonfeld Strategic Advisors
Dimensional Fund Advisors
Citadel Advisors
Bank of New York Mellon
Exchange Traded Concepts

View all funds holding Adicet Bio